Patents by Inventor Mahendra Devichand Chordia

Mahendra Devichand Chordia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL MEK INHIBITORS FOR TREATING CARDIOMYOPATHIES AND RELATED CONDITIONS
    Publication number: 20150250762
    Abstract: The invention pertains to compound of Formula (I) wherein X, Y, Z, R1, R2, R3, R4, A, and A? are described herein. Formula (I) compounds can be used in pharmaceutical compositions, useful for the treatment of disease, in particular cardiovascular conditions and more particularly cardiomyopathies, as well as other related conditions.
    Type: Application
    Filed: April 10, 2015
    Publication date: September 10, 2015
    Inventors: Howard J. Worman, Antoine Muchir, Uday R. Khire, Mahendra Devichand Chordia, Barry Hart
  • MEK inhibitors useful in the treatment of diseases
    Patent number: 9034861
    Abstract: The invention pertains to compound of Formula (I) wherein X, Y, Z, R1, R2, R3, R4, A and A? are as described hereinabove. Formula (I) and (II) compounds can be used in pharmaceutical compositions, useful for the treatment of diseases.
    Type: Grant
    Filed: October 13, 2010
    Date of Patent: May 19, 2015
    Assignee: Allomek Therapeutics LLC
    Inventors: Uday R. Khire, Mahendra Devichand Chordia
  • NOVEL MEK INHIBITORS USEFUL IN THE TREATMENT OF DISEASES
    Publication number: 20120208859
    Abstract: The invention pertains to compound of Formula (I) wherein X, Y, Z, R1, R2, R3, R4, A and A? are as described hereinabove. Formula (I) and (II) compounds can be used in pharmaceutical compositions, useful for the treatment of diseases.
    Type: Application
    Filed: October 13, 2009
    Publication date: August 16, 2012
    Applicant: ALLOSTEM THERAPEUTICS LLC
    Inventors: Uday R. Khire, Mahendra Devichand Chordia
  • 2-Aroyl-4-acyl paclitaxel (taxol) analogs
    Publication number: 20030036661
    Abstract: 2-debenzoyl-4-deacetyl paclitaxel, antineoplastic analogs thereof and intermediates are taught, as well as the formation of the compound, analogs and intermediates. The compound, analogs and intermediates may be used to form pharmaceutical compositions having anti-neoplastic activity. Further, the compound, analogs and intermediates may be used to treat cancer when applied in an effective amount by means such as a pharmaceutical composition.
    Type: Application
    Filed: August 2, 2002
    Publication date: February 20, 2003
    Applicant: Bristol-Myers Squibb Company
    Inventors: David George Ian Kingston, Mahendra Devichand Chordia, Prakash G. Jagtap, John Kadow
  • 2-aroyl-4-acyl paclitaxel (Taxol) analogs
    Patent number: 6476242
    Abstract: 2-debenzoyl-4-deacetyl paclitaxel, antineoplastic analogs thereof and intermediates are taught, as well as the formation of the compound, analogs and intermediates. The compound, analogs and intermediates may be used to form pharmaceutical compositions having anti-neoplastic activity. Further, the compound, analogs and intermediates may be used to treat cancer when applied in an effective amount by means such as a pharmaceutical composition.
    Type: Grant
    Filed: December 30, 1998
    Date of Patent: November 5, 2002
    Assignees: Bristol-Myers Squibb Company, Virginia Tech Intellectual Properties, Inc.
    Inventors: David George Ian Kingston, Mahendra Devichand Chordia, Prakash G. Jagtap, John Kadow